Warning: This security is no longer trading.
Eli Lilly completes acquisition of Loxo Oncology
Loxo Oncology, Inc. (LOXO): Price and Financial Metrics
LOXO Price/Volume Stats
| Current price | $234.80 | 52-week high | $234.93 |
| Prev. close | $234.66 | 52-week low | $103.50 |
| Day low | $234.80 | Volume | 800 |
| Day high | $234.80 | Avg. volume | 1,587,853 |
| 50-day MA | $192.70 | Dividend yield | N/A |
| 200-day MA | $171.03 | Market Cap | 7.19B |
LOXO Stock Price Chart Interactive Chart >
Loxo Oncology, Inc. (LOXO) Company Bio
Loxo Oncology engages in the discovery, development, and commercialization of cancer therapies in the United States. The company's focus is on lung, head and neck, melanoma, colorectal, sarcoma, and breast cancer. The company was founded in 2013 and is based in Stamford, Connecticut.
LOXO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...